Upcoming Events• October 1: Webinar: -59 Modifier and Routine Foot Care Payer Policies |
||
|
|
||
| Sharing News With Your Members Just Got Easier | ||
|
|
||
| There’s now a quick and easy way for you to share the information in this newsletter with your state membership.
We have created a web page with all of the Monthly Focus news written with minimal formatting to make it easy for you to copy and paste the articles into your own communications. We encourage state organizations to share this news with your members to add value and keep them informed of the many benefits of their state and national membership. |
||
| Registration is Open for the 2020 CAC-PIAC Meeting | ||
|
|
||
| Due to the COVID-19 health crisis, the APMA 20th Annual National Podiatric CAC-PIAC Meeting will be virtual. State components and affiliates are encouraged to have their CAC or PIAC rep register for the meeting. Registration closes on December 1. Early registration is highly recommended!
APMA determined this meeting date and logistics based on feedback from members and health policy consultants. The CY 2021 Medicare Physician Fee Schedule will be published late this year because the proposed rule was released almost a month later than usual. A December meeting date gives us time to address the final rule and changes to Medicare reimbursement policy at the meeting. Date: Saturday, December 5 Send questions or comments to APMA staff at healthpolicy.hpp@apma.org. |
||
| Are You Registered To Vote? | ||
|
|
||
| During our Fall Advocacy Week, APMA is encouraging all of its members to make sure they are registered to vote and have a voting plan in place for the November 3 elections.
As a physician, your schedule can change at a moment’s notice so don’t let an emergency stop your voice from being heard. Register now! |
||
| Partner With Us to Address Racism and Disparities Through Educational Programs | ||
|
|
||
| APMA’s Public Health and Preventive Podiatric Medicine Committee (PHPPMC) wants to provide more educational opportunities for members on topics such as racism, implicit bias, and health-care disparities.
On June 2, APMA published new efforts to address racism and disparities. We invite your organization to partner with APMA to develop opportunities such as joint virtual townhalls, expert panel webinars, and articles for your publications. We ask you to commit to encouraging factual and empathetic discourse on this vital topic. Please share your educational programming suggestions with APMA Director of Clinical Affairs Dyane Tower, DPM, MPH, MS, detower@apma.org. |
||
| Discuss Naloxone with Patients When Prescribing Opioids | ||
|
|
||
| In a Drug Safety Communication released in July, the Food and Drug Administration (FDA) recommends health-care professionals discuss naloxone with all patients when prescribing opioid pain relievers or medications to treat opioid use disorder. According to the FDA, health-care professionals should discuss the availability of naloxone, and consider prescribing it to patients who are at increased risk of opioid overdose. Information on naloxone and information specifically for health-care professionals can be found on the FDA’s website. | ||
| Link to APMA’s COVID-19 Resources | ||
|
|
||
| APMA has a wealth of information, including original webinars, articles, and podcasts, available to members to assist them in navigating the COVID-19 health crisis.
These resources cover everything from general information to financial assistance options to reopening your practice in a safe manner. APMA strongly encourages its state components and affiliates to link to these materials from their websites. We have heard from several members who have been unable to find information on their state organizations’ sites. Take advantage of the materials APMA has created. Link to www.apma.org/covid19. |
||
